New FDA guidance on psychedelics changes little for researchers but could open minds and funding sources. The post New FDA Guidance on Psychedelics Could...
Which psychedelics will be next to be FDA approved? We take a closer look. The post Legal Psychedelics: Which Compounds Will Be Approved Next? appeared...
Source: Streetwise Reports 07/12/2023 A non-brokered private placement for a company zeroing in on addiction treatments is being oversubscribed...
Psychedelic drug company Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) has set the date to consolidate its common shares on a five to one basis...
Spravato provides insights into market potential of legal psychedelics - we take a closer look. The post The Commercial Market for Legal Psychedelics:...
On 6th July, PSYCH Symposium returns to London to explore emerging research, technologies and opportunities which have the potential to reshape the landscape...
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights The post Small Pharma Reports 2023 Financial...
Psychedelic stocks have a bright future with 13.5% compound annual growth expected through 2029. That growth will certainly draw in investment funding...
Cybin has reported audited financial results for fiscal year 2023 and recent business highlights. The post Cybin Reports 2023 Financial Results and Business...
Cybin also reached a common share purchase agreement with Lincoln Park Capital Fund. The post Cybin Posts C$47.5 Million Loss for 2023 Fiscal Year appeared...